Attention Laurel Patients:¬† Effective, Tues May 28th, the new Laurel office is open. The address is 7140 Contee Road, Suite 3500, Laurel, MD 20707……¬† Attention¬† Annapolis Patients: The One Community in Care event will be held on June 8th from 11am-2pm in the Annapolis parking lot.

Trial Protocol ID USOR 21455_WO43571_heredERA

Trial Description

A Phase III, Randomized, Open-Label Study Evaluating the Efficacy and Safety of Giredestrant in Combination with Phesgo versus Phesgo after Induction Therapy with Phesgo+Taxane in Patients with Previously Untreated HER2-Positive, Estrogen Receptor-Positive Locally-Advanced or Metastatic Breast Cancer

Contact us regarding Clinical Trials at MOHRSCH@usoncology.com or call us at 877-664-7724

Investigator

  • Jeanine L Werner, M.D.

Disease Types

Sponsor

  • Roche Laboratories, Inc.

ClinicalTrials.gov NCT ID

  • NCT05296798